Is intramuscular (IM) lorazepam (Ativan) effective as a sedative for a patient with irrelevant talk, possibly indicating agitation or confusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lorazepam injection is recommended as a sedative for patients with irrelevant talk, starting with 0.5-2 mg IV or IM, which may be repeated every 4-6 hours as needed, as it is an effective monotherapy for the initial drug treatment of the acutely agitated undifferentiated patient in the ED 1. When administering lorazepam, it is essential to individualize the dose based on the patient's age, weight, and clinical response, with lower doses (0.5-1 mg) recommended for elderly or debilitated patients.

  • The dose should be given slowly at 2 mg/minute or less to minimize respiratory depression and hypotension.
  • Always have resuscitation equipment available when giving parenteral benzodiazepines.
  • Lorazepam works by enhancing the inhibitory neurotransmitter GABA in the brain, producing anxiolytic and sedative effects that can help manage agitation and disorganized thinking.
  • Before using lorazepam, attempt non-pharmacological approaches like reorientation, creating a calm environment, and addressing underlying causes of the patient's confusion.
  • Monitor vital signs, respiratory status, and level of consciousness during treatment, and be aware that benzodiazepines can cause paradoxical reactions in some patients, particularly the elderly.
  • Lorazepam should be used for the shortest duration possible to avoid dependence and withdrawal issues, as recommended by the clinical policy for the management of adult psychiatric patients in the emergency department 1.

From the Research

Sedative Options for Patients with Irrelevant Talk

  • Lorazepam is a benzodiazepine that can be used as a sedative for patients with agitation, including those with irrelevant talk 2, 3, 4.
  • The use of lorazepam as a sedative is often considered in combination with other medications, such as antipsychotics, to manage acute agitation 2, 3, 4.
  • Studies have shown that benzodiazepines, including lorazepam, are less likely to be associated with treatment-emergent side effects compared to antipsychotics 2.
  • However, the effectiveness of lorazepam as a sedative for patients with irrelevant talk may vary depending on the individual patient and the specific clinical context 5, 6.

Comparison with Other Sedatives

  • Midazolam is another benzodiazepine that can be used as a sedative for patients with agitation, and it has been shown to sedate quickly 3.
  • However, midazolam may be restricted to use within an emergency department due to increased saturation problems 3.
  • A study comparing droperidol and midazolam with haloperidol and lorazepam for acute agitation management found that both combinations were safe and effective, but the droperidol and midazolam combination resulted in a lower rate of repeat doses 4.

Clinical Considerations

  • The management of acute agitation, including the use of sedatives like lorazepam, should be tailored to the individual patient and their specific needs 5, 6.
  • Non-pharmacological interventions, such as reality orientation and validation therapy, should be considered as part of a comprehensive approach to managing agitation 6.
  • The use of sedatives like lorazepam should be carefully monitored and adjusted as needed to minimize the risk of adverse effects and ensure optimal patient outcomes 2, 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis.

European psychiatry : the journal of the Association of European Psychiatrists, 2019

Research

Management of the Agitated Patient.

Emergency medicine clinics of North America, 2024

Research

Calming the Agitated Patient: Providing Strategies to Support Clinicians.

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.